← Back to Clinical Trials
Recruiting NCT07103499

NCT07103499 Abdominal and Core Exercises on Respiratory Functions in Obese and Overweight Women (COREBREATH)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07103499
Status Recruiting
Phase
Sponsor Ondokuz Mayıs University
Condition Obesity
Study Type INTERVENTIONAL
Enrollment 48 participants
Start Date 2025-12-15
Primary Completion 2025-12-15

Trial Parameters

Condition Obesity
Sponsor Ondokuz Mayıs University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 48
Sex FEMALE
Min Age 18 Years
Max Age 60 Years
Start Date 2025-12-15
Completion 2025-12-15
Interventions
Pilates-Based Core and Breathing Exercise Program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study aims to examine the effects of an 8-week Pilates-based exercise program on breathing functions in overweight and obese women (BMI ≥ 25). The program includes exercises for abdominal endurance and core stabilization, performed three times a week. Participants will be divided into two groups: an exercise group and a control group. Before and after the program, measurements will include lung function (spirometry), breathing rate, breath-holding time, abdominal mobility, core endurance (curl-up test), and quality of life (SF-36 questionnaire). The goal is to find out whether this type of exercise can improve breathing and overall health in women with excess weight.

Eligibility Criteria

inclusion criteria 1. Women aged 18-60 2. Body mass index (BMI) ≥ 25 kg/m² (obese and overweight) 3. Baseline FEV0 value ≥ 80% (measured by spirometry) 4. Individuals without respiratory disease (no diagnosis of asthma, COPD, etc.) 5. Individuals who have not engaged in regular exercise in the past 6 months 6. Individuals without orthopedic or neurological conditions that physically prevent participation in the exercise protocol 7. Non-pregnant individuals 8. Individuals who voluntarily agree to participate in the study and sign the informed consent form exclusion criteria 1\. Individuals with a FEV0 value \<80% (due to risk of obstructive lung disease) 2. Individuals who have undergone surgery in the abdomen, waist, or pelvic area within the last 6 months 3. Individuals with orthopedic, neurological, or systemic diseases that would prevent them from exercising 4. Individuals who have been engaging in regular exercise for 3 or more days per week in the past 3 months 5. Individuals with

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology